文献速递膀胱癌与上尿路尿路上皮癌肾癌与肾肿瘤泌尿系感染

局部晚期与复发性直肠癌全盆腔脏器切除术后的泌尿系统结局与不良事件:单中心回顾性研究

Urological Outcomes and Adverse Events Following Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: A Single-center Retrospective Study.
PubMed 文献 · Urology · 2024-12-20

单中心回顾性研究纳入2017年1月至2022年12月接受全盆腔脏器切除术的128例患者(局部晚期直肠癌97例、复发性直肠癌31例),泌尿系统并发症总发生率为51.6%,以短暂性急性肾损伤和尿路感染最常见;泌尿系统并发症总体发生率与放疗状态及局部晚期与复发性直肠癌分组均无关联。

要点

  • 全盆腔脏器切除术后泌尿系统并发症总发生率为51.6%。
  • 短暂性急性肾损伤38例(29.7%)、尿路感染33例(25.8%)最常见。
  • 泌尿系统并发症总体发生率与放疗状态及局部晚期与复发性分组均无关联。

核心结论

  • 全盆腔脏器切除术后泌尿系统并发症常见,局部晚期直肠癌与复发性直肠癌的泌尿系统并发症发生率相似,本队列中放疗状态未影响结局。

研究设计与样本

  • 单中心、回顾性研究,纳入2017年1月至2022年12月期间接受全盆腔脏器切除术的患者,共128例(局部晚期直肠癌97例、复发性直肠癌31例),通过电子病历提取数据。

主要发现

  • 90例(70.3%)接受新辅助放疗,泌尿系统并发症总体发生率为51.6%。
  • 短暂性急性肾损伤38例(29.7%)、尿路感染33例(25.8%)为最常见的两种并发症。
  • 23例(18.0%)发生至少一次与泌尿系统相关的Clavien-Dindo III/IV级重大并发症。
  • 输尿管肠吻合口狭窄率为7.0%,14.1%因泌尿系统并发症需再次手术。
  • 泌尿系统并发症总体发生率与放疗状态无关联(OR 0.81 [0.37-1.73],P=.586),局部晚期直肠癌与复发性直肠癌之间亦无关联(OR 1.68 [0.75-3.93],P=.216)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess urological complications in patients undergoing total pelvic exenteration (TPE) for locally advanced (LARC) and recurrent rectal cancer (RRC) as publications in this area are limited. Secondary objectives were to assess whether LARC vs RRC or radiation status affected urological outcomes. METHODS: Single-center, retrospective study of TPE patients between January 2017 and December 2022. Electronic records were evaluated to extract data. Postoperative outcomes were analyzed using two-tailed t-tests, Mann-Whitney U tests and chi-squared tests. Urological complications were analyzed using simple logistic regression. RESULTS: A total of 128 patients underwent TPE (97 LARC, 31 RRC). 90 (70.3%) received neoadjuvant radiotherapy. The overall urological complication rate was 51.6%. Transient acute kidney injury and urinary tract infection were the two most common complications occurring in 38 (29.7%) and 33 (25.8%) respectively. 23 (18.0%) had at least one major complication of Clavien-Dindo III/IV related to the urinary system. Ureteroenteric stricture rate was 7.0% and 14.1% needed a reoperation for urological complications. There was no association between the overall incidence of urological complications and radiation status (OR 0.81 [0.37-1.73], P=.586) or between patients with LARC and RRC (OR 1.68 [0.75-3.93], P=.216). CONCLUSION: Urological complications are common post-TPE. The urological complication rate is similar in LARC and RRC and radiation status did not affect outcomes in this cohort.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Kerdegari N, Singh CT, MacAskill F, et al. Urological Outcomes and Adverse Events Following Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: A Single-center Retrospective Study. Urology. 2024. PMID: 39710077. doi:10.1016/j.urology.2024.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。